Anti-CGRP and Anti-CGRP Receptor Monoclonal Antibodies for Migraine Prophylaxis: Retrospective Observational Study on 209 Patients
Background: Migraine is a neurological disorder characterized by attacks of head pain with prevalent unilateral localization, moderate to high intensity and specifically associated accompanying symptoms. Methods: In this retrospective observational study, we analyzed data regarding 209 patients who...
Main Authors: | Vittorio Schweiger, Paola Bellamoli, Francesco Taus, Leonardo Gottin, Alvise Martini, Marta Nizzero, Eleonora Bonora, Giovanna Del Balzo, Katia Donadello, Erica Secchettin, Gabriele Finco, Daniele De Santis, Enrico Polati |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-02-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/13/4/1130 |
Similar Items
-
CGRP: New Focus in Migraine
by: Necdet Karlı, et al.
Published: (2022-03-01) -
Nutrition and Calcitonin Gene Related Peptide (CGRP) in Migraine
by: Michal Fila, et al.
Published: (2023-01-01) -
The Anti-Calcitonin Gene-Related Peptide (Anti-CGRP) Antibody Fremanezumab Reduces Trigeminal Neurons Immunoreactive to CGRP and CGRP Receptor Components in Rats
by: Birgit Vogler, et al.
Published: (2023-08-01) -
Mode and site of action of therapies targeting CGRP signaling
by: Alejandro Labastida-Ramírez, et al.
Published: (2023-09-01) -
Rodent behavior following a dural inflammation model with anti-CGRP migraine medication treatment
by: Philip V. Reducha, et al.
Published: (2023-02-01)